Translating cancer biology into medicines March 15, 2021 33rd Annual Roth Conference Disclaimer This presentation contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 about financial results and estimates, business strategy, clinical trial plans and research and development programs of Cyclacel Pharmaceuticals, Inc. ("Cyclacel"). By their nature, forward-looking statements and forecasts involve risks and uncertainties ...